Lutronic: Aesthetic Aesthetic Menu Close
See All Press Releases

Lutronic Features the CLARITY™ Dual-Wavelength Platform and Hosts the 3rd Annual Aesthetic Laser Dinner Symposium at the Annual Meeting of the American Academy of Dermatology (AAD) in Miami Beach, Florida.

Lutronic, a leading innovator of aesthetic and medical technology, will feature their newest addition, CLARITY™, a long-pulsed Alexandrite and Nd:YAG 2-in-1 platform for multiple applications, at AAD on March 1st 2013 in Miami Beach, Florida. Their exhibit (booth #2325) will provide physicians with hands-on opportunities with the SPECTRA, recently cleared by the FDA for Melasma, and in-booth presentations by skilled clinicians from around the globe sharing their experience with cutting edge technology and methods.

Additionally, Lutronic will host their 3rd Annual Aesthetic Laser Dinner Symposium on March 2nd; this complimentary event will feature prominent physicians including Dr. Melanie Palm (USA), Dr. Ivan Perez (Columbia) and Dr. Omar Ibrahimi (USA).  They will share their professional knowledge with Fractional RF technology, advancements in hair removal, and the use of CO2 lasers beyond standard applications. There will also be a round table discussion panel about the many uses of the Spectra. Seating is limited for this event, so be sure to check out the complete agenda and register at: or stop by the Lutronic exhibit.

This year, Lutronic's exhibit will feature in-booth presentations by leading physicians from around the globe who will discuss and share their experience using aesthetic lasers. These physicians will include, Dr. Jagdish Sakhiya (India), Dr. Melanie Palm (USA), Dr. B. C. Goo (Korea), and Dr. Ivan Perez (Colombia).

Also being featured by Lutronic at AAD will be SPECTRA™, a Dual-pulsed Q-switched Nd:YAG laser and the first of its kind to be FDA cleared for the treatment of melasma; INFINI, a 2-in-1 fractional RF system which has two treatment modalities, MFR and SFR, in one platform; ADVANTAGE, a high energy pulsed diode laser system for hair removal and permanent hair reduction; eCO2, a fractional CO2 with Lutronic’s own patented Controlled Chaos Technology™; and HEALITE II, an 830 nm LED phototherapy system that enhances recovery, ideal for post procedure treatment.

CLARITY is one of the most versatile dual-wavelength platforms on the market, with multiple indications for top aesthetic laser physicians worldwide. With two workhorse wavelengths, the long-pulsed 755 nm Alexandrite and 1064 nm Nd:YAG, in one easy- to-use device, physicians may gently remove pigmented lesions, unwanted hair, tighten skin, and ameliorate the appearance of vascular lesions. CLARITY customers may choose between single- or double- wavelength configurations, in addition to air cooling or built-in cryogen spray cooling, which is typically preferred for improved patient comfort without topical anesthetics. At this time, Lutronic has two patents pending for its Intelligent Cooling Device (ICD).  CLARITY received the CE mark in June 2012; it is not yet for sale in the US, and is pending FDA clearance. CLARITY joins Lutronic's robust portfolio that is hailed in the aesthetic industry for its high value devices that doctors find both intuitive and convenient.

Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 15 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems.  All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, skin resurfacing, body/facial contouring, chronic pain and more. 

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 130 current and pending patents worldwide. With more than 230 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, a worldwide network of distributors, and is ever expanding.